Stay updated on Lenvatinib Pembrolizumab in Hepatobiliary Tumors Clinical Trial

Sign up to get notified when there's something new on the Lenvatinib Pembrolizumab in Hepatobiliary Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenvatinib Pembrolizumab in Hepatobiliary Tumors Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Footer now shows Revision: v3.6.6, replacing Revision: v3.6.5, indicating a platform revision update rather than a change to the study content.
    Difference
    0.1%
    Check dated 2026-09-01T19:27:26.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.4 to v3.6.5, indicating a new version of the page without changes to study content.
    Difference
    0.1%
    Check dated 2026-08-11T19:43:53.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.6.4, replacing the previous Revision: v3.6.3. This appears to be a technical update to the page version rather than a change to study data or presentation.
    Difference
    0.1%
    Check dated 2026-07-21T12:48:38.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.0 to v3.6.3, reflecting a minor backend/metadata update to the page.
    Difference
    0.1%
    Check dated 2026-06-30T00:39:49.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Introduces new help and navigation sections and a recruitment-status note; updates the Intervention/Treatment label and bumps the site revision to v3.6.0, replacing the older 'Intervention / Treatment' label and the v3.5.5 reference.
    Difference
    0.4%
    Check dated 2026-06-15T21:54:30.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.4 to v3.5.5, indicating a new version of the study record that likely reflects minor maintenance or backend updates.
    Difference
    0.1%
    Check dated 2026-06-08T16:48:27.000Z thumbnail image

Stay in the know with updates to Lenvatinib Pembrolizumab in Hepatobiliary Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenvatinib Pembrolizumab in Hepatobiliary Tumors Clinical Trial page.